Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5829063 | European Journal of Pharmacology | 2013 | 6 Pages |
Abstract
For decades, platinum drugs have been the mainstay of cancer treatment. However, over time, drug resistance develops, leaving few treatment options. Here we show that platelet-derived growth factor α receptor (PDGF α receptor)-mediated signaling plays a key role in hepatocyte growth factor (HGF) receptor (c-Met) upregulation, which in turn is thought to play an important role in chemotherapy resistance. PDGF α receptor inhibition eliminates cisplatin-dependent Met expression in cervical cancer cell lines. PDGF α receptor inhibitors are widely used in clinical settings, suggesting that the clinical translation of our findings could reduce the suffering of people from drug resistance.
Keywords
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Shinichiro Kina, Thongsavanh Phonaphonh, Feixin Liang, Hai Kuang, Akira Arasaki, Keiichi Arakaki, Toshiyuki Nakasone, Hajime Sunakawa,